Manipal Hospitals is reportedly reducing its initial public offering valuation from an earlier estimate of $10 billion to $12 billion [1].
The move signals a cautious approach to pricing as the company prepares to enter the public market. A lower valuation may be necessary to ensure investor appetite and a successful debut on Indian stock exchanges.
Reports indicate the revised valuation is now approximately $8.3 billion [2]. Despite this reduction, the offering is expected to be the largest IPO of 2026, surpassing the SBI Funds IPO with a value exceeding $1 billion [1].
The proposed issue size is expected to be close to $1 billion [3]. This offering includes a fresh issue of shares worth 80 billion rupees [2]. Additionally, the company plans an offer for sale of 43.23 million existing shares [2].
The Temasek-backed chain has already received approval from the Securities and Exchange Board of India (SEBI) [3]. Manipal Hospitals aims to complete the process and list by the end of July [3].
Company representatives have not provided a public explanation for the valuation shift. The adjustment follows a period of high expectations for healthcare sector listings in India.
“Manipal Hospitals is reportedly reducing its initial public offering valuation from an earlier estimate of $10 billion to $12 billion”
The downward revision of Manipal Hospitals' valuation suggests a gap between internal company projections and current market appetite for healthcare assets. By lowering the target to $8.3 billion, the company is likely attempting to avoid an underpriced or failed offering, while still maintaining its position as the year's largest IPO to signal strength to the market.
